Becton Dickinson and Co
Change company Symbol lookup
Select an option...
BDX Becton Dickinson and Co
OMC Omnicom Group Inc
MSFT Microsoft Corp
ACC American Campus Communities Inc
PNFP Pinnacle Financial Partners Inc
SYF Synchrony Financial
TRV Travelers Companies Inc
IBM International Business Machines Corp
T AT&T Inc
MRK Merck & Co Inc
Go

Health Care : Health Care Equipment & Supplies | Large Cap Value
Company profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Closing Price
$256.44
Day's Change
-2.52 (-0.97%)
Bid
--
Ask
--
B/A Size
--
Day's High
260.60
Day's Low
256.18
Volume
(Above Average)
Volume:
1,495,754

10-day average volume:
1,296,201
1,495,754

Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Valuation Ratios

Price/Earnings (TTM)
49.77x
Price/Sales (TTM)
4.13x
Price/Book (MRQ)
3.05x
Price/Cash Flow (TTM)
20.41x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend

Short Interest

March 2021
Current Month
2.1M
Previous Month
2.3M
Percent of Float
0.74%
Days to Cover
2.0607 Days

Share Information

BDX is in a share class of common stock
Float
288.6M
Shares Outstanding
290.6M
Institutions Holding Shares
1,957
83.94%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Vincent A. ForlenzaChmn.
  • Thomas E. PolenChmn.
  • Christopher R. ReidyCFO
  • David HickeyCorp.Exec.
  • Betty D. Larson

Address

Insider Trading

During the most recent quarter, 930 shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.